Company / Working Capital
Royalty Pharma plc Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$891.9M
FY2025
5-year range
$548.5M / $2.7B
FY2021-FY2025
Trend
+62.6%
vs FY2024
Sector context
#45 of 213
Health Care
What the data says
Royalty Pharma plc's working capital of $892M is higher than 79% of companies in the Health Care sector (FY2025). Working Capital returned to growth in FY2025 after 3 years of decline, reaching $892M.
Based on SEC 10-K filings.
$892M in FY2025 with a 5-year CAGR of -17.9%. Top quartile in the Health Care sector.
Declined from $1.1B to $892M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -13.7%
- 5-Year CAGR
- -17.9%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 213This company $891.9M Sector average $934.6M
▼
-4.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -17.9%, indicating a declining trend.
- In FY2025, working capital increased 62.6% year-over-year.
- Ranks #45 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- Strong profit margin: 38.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $891.9M | +62.6% |
| FY2024 | $548.5M | -50.7% |
| FY2023 | $1.1B | -19.8% |
| FY2022 | $1.4B | -48.7% |
| FY2021 | $2.7B | +13.3% |
| FY2020 | $2.4B | +379.1% |
| FY2019 | $498.7M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026